FDA Approves GE's Low-Dose CT Device For Lung Cancer Screening

The U.S. Food and Drug Administration (FDA) has granted GE Healthcare's low-dose computed tomography (CT) devicea screening indication for the early detection of lung cancer, making GE the first manufacturer to receive such clearance.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news